Cytheris gets US patent covering preparation & uses of Glycosylated IL-7
Thursday, February 04, 2010 17:00 IST Paris
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, has received a Notice of Allowance from the US Patent and Trademark Office